Global Meningitis B Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Meningitis B Vaccine Industry Forecast” looks at past sales and reviews total world Meningitis B Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Meningitis B Vaccine sales for 2023 through 2029. With Meningitis B Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningitis B Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Meningitis B Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningitis B Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Meningitis B Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningitis B Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningitis B Vaccine.
The global Meningitis B Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Meningitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Meningitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Meningitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Meningitis B Vaccine players cover GlaxoSmithKline, Chengdu Institute of Biological Products Co., Ltd., Novartis, BEXSERO, TRUMENBA, Pfizer, Sanofi Pasteur Inc and Wyeth Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningitis B Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Meningitis B Vaccine market?
What factors are driving Meningitis B Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningitis B Vaccine market opportunities vary by end market size?
How does Meningitis B Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Meningitis B Vaccine Industry Forecast” looks at past sales and reviews total world Meningitis B Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Meningitis B Vaccine sales for 2023 through 2029. With Meningitis B Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningitis B Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Meningitis B Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningitis B Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Meningitis B Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningitis B Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningitis B Vaccine.
The global Meningitis B Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Meningitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Meningitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Meningitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Meningitis B Vaccine players cover GlaxoSmithKline, Chengdu Institute of Biological Products Co., Ltd., Novartis, BEXSERO, TRUMENBA, Pfizer, Sanofi Pasteur Inc and Wyeth Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningitis B Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- MenACWY (Conjugate) Vaccine
- MenB (Recombinant Protein) Vaccine
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Chengdu Institute of Biological Products Co., Ltd.
- Novartis
- BEXSERO
- TRUMENBA
- Pfizer
- Sanofi Pasteur Inc
- Wyeth Pharmaceuticals, Inc.
What is the 10-year outlook for the global Meningitis B Vaccine market?
What factors are driving Meningitis B Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningitis B Vaccine market opportunities vary by end market size?
How does Meningitis B Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meningitis B Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Meningitis B Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Meningitis B Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Meningitis B Vaccine Segment by Type
2.2.1 MenACWY (Conjugate) Vaccine
2.2.2 MenB (Recombinant Protein) Vaccine
2.3 Meningitis B Vaccine Sales by Type
2.3.1 Global Meningitis B Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Meningitis B Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Meningitis B Vaccine Sale Price by Type (2018-2023)
2.4 Meningitis B Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Meningitis B Vaccine Sales by Application
2.5.1 Global Meningitis B Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Meningitis B Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Meningitis B Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MENINGITIS B VACCINE BY COMPANY
3.1 Global Meningitis B Vaccine Breakdown Data by Company
3.1.1 Global Meningitis B Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Meningitis B Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Meningitis B Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Meningitis B Vaccine Revenue by Company (2018-2023)
3.2.2 Global Meningitis B Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Meningitis B Vaccine Sale Price by Company
3.4 Key Manufacturers Meningitis B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningitis B Vaccine Product Location Distribution
3.4.2 Players Meningitis B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MENINGITIS B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Meningitis B Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Meningitis B Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Meningitis B Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Meningitis B Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Meningitis B Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Meningitis B Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Meningitis B Vaccine Sales Growth
4.4 APAC Meningitis B Vaccine Sales Growth
4.5 Europe Meningitis B Vaccine Sales Growth
4.6 Middle East & Africa Meningitis B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Meningitis B Vaccine Sales by Country
5.1.1 Americas Meningitis B Vaccine Sales by Country (2018-2023)
5.1.2 Americas Meningitis B Vaccine Revenue by Country (2018-2023)
5.2 Americas Meningitis B Vaccine Sales by Type
5.3 Americas Meningitis B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningitis B Vaccine Sales by Region
6.1.1 APAC Meningitis B Vaccine Sales by Region (2018-2023)
6.1.2 APAC Meningitis B Vaccine Revenue by Region (2018-2023)
6.2 APAC Meningitis B Vaccine Sales by Type
6.3 APAC Meningitis B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meningitis B Vaccine by Country
7.1.1 Europe Meningitis B Vaccine Sales by Country (2018-2023)
7.1.2 Europe Meningitis B Vaccine Revenue by Country (2018-2023)
7.2 Europe Meningitis B Vaccine Sales by Type
7.3 Europe Meningitis B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meningitis B Vaccine by Country
8.1.1 Middle East & Africa Meningitis B Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Meningitis B Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Meningitis B Vaccine Sales by Type
8.3 Middle East & Africa Meningitis B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningitis B Vaccine
10.3 Manufacturing Process Analysis of Meningitis B Vaccine
10.4 Industry Chain Structure of Meningitis B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningitis B Vaccine Distributors
11.3 Meningitis B Vaccine Customer
12 WORLD FORECAST REVIEW FOR MENINGITIS B VACCINE BY GEOGRAPHIC REGION
12.1 Global Meningitis B Vaccine Market Size Forecast by Region
12.1.1 Global Meningitis B Vaccine Forecast by Region (2024-2029)
12.1.2 Global Meningitis B Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningitis B Vaccine Forecast by Type
12.7 Global Meningitis B Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Meningitis B Vaccine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Chengdu Institute of Biological Products Co., Ltd.
13.2.1 Chengdu Institute of Biological Products Co., Ltd. Company Information
13.2.2 Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Product Portfolios and Specifications
13.2.3 Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Chengdu Institute of Biological Products Co., Ltd. Main Business Overview
13.2.5 Chengdu Institute of Biological Products Co., Ltd. Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Meningitis B Vaccine Product Portfolios and Specifications
13.3.3 Novartis Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 BEXSERO
13.4.1 BEXSERO Company Information
13.4.2 BEXSERO Meningitis B Vaccine Product Portfolios and Specifications
13.4.3 BEXSERO Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BEXSERO Main Business Overview
13.4.5 BEXSERO Latest Developments
13.5 TRUMENBA
13.5.1 TRUMENBA Company Information
13.5.2 TRUMENBA Meningitis B Vaccine Product Portfolios and Specifications
13.5.3 TRUMENBA Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TRUMENBA Main Business Overview
13.5.5 TRUMENBA Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Meningitis B Vaccine Product Portfolios and Specifications
13.6.3 Pfizer Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi Pasteur Inc
13.7.1 Sanofi Pasteur Inc Company Information
13.7.2 Sanofi Pasteur Inc Meningitis B Vaccine Product Portfolios and Specifications
13.7.3 Sanofi Pasteur Inc Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Pasteur Inc Main Business Overview
13.7.5 Sanofi Pasteur Inc Latest Developments
13.8 Wyeth Pharmaceuticals, Inc.
13.8.1 Wyeth Pharmaceuticals, Inc. Company Information
13.8.2 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Portfolios and Specifications
13.8.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wyeth Pharmaceuticals, Inc. Main Business Overview
13.8.5 Wyeth Pharmaceuticals, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meningitis B Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Meningitis B Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Meningitis B Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Meningitis B Vaccine Segment by Type
2.2.1 MenACWY (Conjugate) Vaccine
2.2.2 MenB (Recombinant Protein) Vaccine
2.3 Meningitis B Vaccine Sales by Type
2.3.1 Global Meningitis B Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Meningitis B Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Meningitis B Vaccine Sale Price by Type (2018-2023)
2.4 Meningitis B Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Meningitis B Vaccine Sales by Application
2.5.1 Global Meningitis B Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Meningitis B Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Meningitis B Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MENINGITIS B VACCINE BY COMPANY
3.1 Global Meningitis B Vaccine Breakdown Data by Company
3.1.1 Global Meningitis B Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Meningitis B Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Meningitis B Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Meningitis B Vaccine Revenue by Company (2018-2023)
3.2.2 Global Meningitis B Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Meningitis B Vaccine Sale Price by Company
3.4 Key Manufacturers Meningitis B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningitis B Vaccine Product Location Distribution
3.4.2 Players Meningitis B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MENINGITIS B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Meningitis B Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Meningitis B Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Meningitis B Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Meningitis B Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Meningitis B Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Meningitis B Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Meningitis B Vaccine Sales Growth
4.4 APAC Meningitis B Vaccine Sales Growth
4.5 Europe Meningitis B Vaccine Sales Growth
4.6 Middle East & Africa Meningitis B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Meningitis B Vaccine Sales by Country
5.1.1 Americas Meningitis B Vaccine Sales by Country (2018-2023)
5.1.2 Americas Meningitis B Vaccine Revenue by Country (2018-2023)
5.2 Americas Meningitis B Vaccine Sales by Type
5.3 Americas Meningitis B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningitis B Vaccine Sales by Region
6.1.1 APAC Meningitis B Vaccine Sales by Region (2018-2023)
6.1.2 APAC Meningitis B Vaccine Revenue by Region (2018-2023)
6.2 APAC Meningitis B Vaccine Sales by Type
6.3 APAC Meningitis B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meningitis B Vaccine by Country
7.1.1 Europe Meningitis B Vaccine Sales by Country (2018-2023)
7.1.2 Europe Meningitis B Vaccine Revenue by Country (2018-2023)
7.2 Europe Meningitis B Vaccine Sales by Type
7.3 Europe Meningitis B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meningitis B Vaccine by Country
8.1.1 Middle East & Africa Meningitis B Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Meningitis B Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Meningitis B Vaccine Sales by Type
8.3 Middle East & Africa Meningitis B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningitis B Vaccine
10.3 Manufacturing Process Analysis of Meningitis B Vaccine
10.4 Industry Chain Structure of Meningitis B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningitis B Vaccine Distributors
11.3 Meningitis B Vaccine Customer
12 WORLD FORECAST REVIEW FOR MENINGITIS B VACCINE BY GEOGRAPHIC REGION
12.1 Global Meningitis B Vaccine Market Size Forecast by Region
12.1.1 Global Meningitis B Vaccine Forecast by Region (2024-2029)
12.1.2 Global Meningitis B Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningitis B Vaccine Forecast by Type
12.7 Global Meningitis B Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Meningitis B Vaccine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Chengdu Institute of Biological Products Co., Ltd.
13.2.1 Chengdu Institute of Biological Products Co., Ltd. Company Information
13.2.2 Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Product Portfolios and Specifications
13.2.3 Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Chengdu Institute of Biological Products Co., Ltd. Main Business Overview
13.2.5 Chengdu Institute of Biological Products Co., Ltd. Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Meningitis B Vaccine Product Portfolios and Specifications
13.3.3 Novartis Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 BEXSERO
13.4.1 BEXSERO Company Information
13.4.2 BEXSERO Meningitis B Vaccine Product Portfolios and Specifications
13.4.3 BEXSERO Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BEXSERO Main Business Overview
13.4.5 BEXSERO Latest Developments
13.5 TRUMENBA
13.5.1 TRUMENBA Company Information
13.5.2 TRUMENBA Meningitis B Vaccine Product Portfolios and Specifications
13.5.3 TRUMENBA Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TRUMENBA Main Business Overview
13.5.5 TRUMENBA Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Meningitis B Vaccine Product Portfolios and Specifications
13.6.3 Pfizer Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi Pasteur Inc
13.7.1 Sanofi Pasteur Inc Company Information
13.7.2 Sanofi Pasteur Inc Meningitis B Vaccine Product Portfolios and Specifications
13.7.3 Sanofi Pasteur Inc Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Pasteur Inc Main Business Overview
13.7.5 Sanofi Pasteur Inc Latest Developments
13.8 Wyeth Pharmaceuticals, Inc.
13.8.1 Wyeth Pharmaceuticals, Inc. Company Information
13.8.2 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Portfolios and Specifications
13.8.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wyeth Pharmaceuticals, Inc. Main Business Overview
13.8.5 Wyeth Pharmaceuticals, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Meningitis B Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Meningitis B Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of MenACWY (Conjugate) Vaccine
Table 4. Major Players of MenB (Recombinant Protein) Vaccine
Table 5. Global Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Meningitis B Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Meningitis B Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Meningitis B Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Meningitis B Vaccine Revenue by Application (2018-2023)
Table 13. Global Meningitis B Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Meningitis B Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Meningitis B Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Meningitis B Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Meningitis B Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Meningitis B Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Meningitis B Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Meningitis B Vaccine Producing Area Distribution and Sales Area
Table 21. Players Meningitis B Vaccine Products Offered
Table 22. Meningitis B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meningitis B Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Meningitis B Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Meningitis B Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Meningitis B Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Meningitis B Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Meningitis B Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Meningitis B Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Meningitis B Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Meningitis B Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Meningitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Meningitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Meningitis B Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Meningitis B Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Meningitis B Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Meningitis B Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Meningitis B Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Meningitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Meningitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Meningitis B Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Meningitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Meningitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Meningitis B Vaccine
Table 58. Key Market Challenges & Risks of Meningitis B Vaccine
Table 59. Key Industry Trends of Meningitis B Vaccine
Table 60. Meningitis B Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Meningitis B Vaccine Distributors List
Table 63. Meningitis B Vaccine Customer List
Table 64. Global Meningitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Meningitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Meningitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Meningitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Meningitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Meningitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Meningitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Meningitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Meningitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Meningitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Meningitis B Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Meningitis B Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Meningitis B Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Meningitis B Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GlaxoSmithKline Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Meningitis B Vaccine Product Portfolios and Specifications
Table 80. GlaxoSmithKline Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Chengdu Institute of Biological Products Co., Ltd. Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Product Portfolios and Specifications
Table 85. Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Chengdu Institute of Biological Products Co., Ltd. Main Business
Table 87. Chengdu Institute of Biological Products Co., Ltd. Latest Developments
Table 88. Novartis Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Meningitis B Vaccine Product Portfolios and Specifications
Table 90. Novartis Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. BEXSERO Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. BEXSERO Meningitis B Vaccine Product Portfolios and Specifications
Table 95. BEXSERO Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. BEXSERO Main Business
Table 97. BEXSERO Latest Developments
Table 98. TRUMENBA Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. TRUMENBA Meningitis B Vaccine Product Portfolios and Specifications
Table 100. TRUMENBA Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. TRUMENBA Main Business
Table 102. TRUMENBA Latest Developments
Table 103. Pfizer Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Meningitis B Vaccine Product Portfolios and Specifications
Table 105. Pfizer Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sanofi Pasteur Inc Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Pasteur Inc Meningitis B Vaccine Product Portfolios and Specifications
Table 110. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi Pasteur Inc Main Business
Table 112. Sanofi Pasteur Inc Latest Developments
Table 113. Wyeth Pharmaceuticals, Inc. Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Portfolios and Specifications
Table 115. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Wyeth Pharmaceuticals, Inc. Main Business
Table 117. Wyeth Pharmaceuticals, Inc. Latest Developments
Table 1. Meningitis B Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Meningitis B Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of MenACWY (Conjugate) Vaccine
Table 4. Major Players of MenB (Recombinant Protein) Vaccine
Table 5. Global Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Meningitis B Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Meningitis B Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Meningitis B Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Meningitis B Vaccine Revenue by Application (2018-2023)
Table 13. Global Meningitis B Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Meningitis B Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Meningitis B Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Meningitis B Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Meningitis B Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Meningitis B Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Meningitis B Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Meningitis B Vaccine Producing Area Distribution and Sales Area
Table 21. Players Meningitis B Vaccine Products Offered
Table 22. Meningitis B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meningitis B Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Meningitis B Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Meningitis B Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Meningitis B Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Meningitis B Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Meningitis B Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Meningitis B Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Meningitis B Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Meningitis B Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Meningitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Meningitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Meningitis B Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Meningitis B Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Meningitis B Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Meningitis B Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Meningitis B Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Meningitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Meningitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Meningitis B Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Meningitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Meningitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Meningitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Meningitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Meningitis B Vaccine
Table 58. Key Market Challenges & Risks of Meningitis B Vaccine
Table 59. Key Industry Trends of Meningitis B Vaccine
Table 60. Meningitis B Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Meningitis B Vaccine Distributors List
Table 63. Meningitis B Vaccine Customer List
Table 64. Global Meningitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Meningitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Meningitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Meningitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Meningitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Meningitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Meningitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Meningitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Meningitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Meningitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Meningitis B Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Meningitis B Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Meningitis B Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Meningitis B Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GlaxoSmithKline Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Meningitis B Vaccine Product Portfolios and Specifications
Table 80. GlaxoSmithKline Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Chengdu Institute of Biological Products Co., Ltd. Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Product Portfolios and Specifications
Table 85. Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Chengdu Institute of Biological Products Co., Ltd. Main Business
Table 87. Chengdu Institute of Biological Products Co., Ltd. Latest Developments
Table 88. Novartis Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Meningitis B Vaccine Product Portfolios and Specifications
Table 90. Novartis Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. BEXSERO Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. BEXSERO Meningitis B Vaccine Product Portfolios and Specifications
Table 95. BEXSERO Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. BEXSERO Main Business
Table 97. BEXSERO Latest Developments
Table 98. TRUMENBA Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. TRUMENBA Meningitis B Vaccine Product Portfolios and Specifications
Table 100. TRUMENBA Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. TRUMENBA Main Business
Table 102. TRUMENBA Latest Developments
Table 103. Pfizer Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Meningitis B Vaccine Product Portfolios and Specifications
Table 105. Pfizer Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sanofi Pasteur Inc Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Pasteur Inc Meningitis B Vaccine Product Portfolios and Specifications
Table 110. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi Pasteur Inc Main Business
Table 112. Sanofi Pasteur Inc Latest Developments
Table 113. Wyeth Pharmaceuticals, Inc. Basic Information, Meningitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Portfolios and Specifications
Table 115. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Wyeth Pharmaceuticals, Inc. Main Business
Table 117. Wyeth Pharmaceuticals, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Meningitis B Vaccine
Figure 2. Meningitis B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningitis B Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Meningitis B Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Meningitis B Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of MenACWY (Conjugate) Vaccine
Figure 10. Product Picture of MenB (Recombinant Protein) Vaccine
Figure 11. Global Meningitis B Vaccine Sales Market Share by Type in 2022
Figure 12. Global Meningitis B Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Meningitis B Vaccine Consumed in Hospital
Figure 14. Global Meningitis B Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Meningitis B Vaccine Consumed in Clinic
Figure 16. Global Meningitis B Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Meningitis B Vaccine Sales Market Share by Application (2022)
Figure 18. Global Meningitis B Vaccine Revenue Market Share by Application in 2022
Figure 19. Meningitis B Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Meningitis B Vaccine Sales Market Share by Company in 2022
Figure 21. Meningitis B Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Meningitis B Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Meningitis B Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Meningitis B Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Meningitis B Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Meningitis B Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Meningitis B Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Meningitis B Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Meningitis B Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Meningitis B Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Meningitis B Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Meningitis B Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Meningitis B Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Meningitis B Vaccine
Figure 72. Industry Chain Structure of Meningitis B Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Meningitis B Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Meningitis B Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Meningitis B Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Meningitis B Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Meningitis B Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Meningitis B Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Meningitis B Vaccine
Figure 2. Meningitis B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningitis B Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Meningitis B Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Meningitis B Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of MenACWY (Conjugate) Vaccine
Figure 10. Product Picture of MenB (Recombinant Protein) Vaccine
Figure 11. Global Meningitis B Vaccine Sales Market Share by Type in 2022
Figure 12. Global Meningitis B Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Meningitis B Vaccine Consumed in Hospital
Figure 14. Global Meningitis B Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Meningitis B Vaccine Consumed in Clinic
Figure 16. Global Meningitis B Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Meningitis B Vaccine Sales Market Share by Application (2022)
Figure 18. Global Meningitis B Vaccine Revenue Market Share by Application in 2022
Figure 19. Meningitis B Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Meningitis B Vaccine Sales Market Share by Company in 2022
Figure 21. Meningitis B Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Meningitis B Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Meningitis B Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Meningitis B Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Meningitis B Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Meningitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Meningitis B Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Meningitis B Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Meningitis B Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Meningitis B Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Meningitis B Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Meningitis B Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Meningitis B Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Meningitis B Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Meningitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Meningitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Meningitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Meningitis B Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Meningitis B Vaccine
Figure 72. Industry Chain Structure of Meningitis B Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Meningitis B Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Meningitis B Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Meningitis B Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Meningitis B Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Meningitis B Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Meningitis B Vaccine Revenue Market Share Forecast by Application (2024-2029)
